Daily Stock Analysis, IAU, INTEGRA LIFESCIENCES HOLDING, priceseries

INTEGRA LIFESCIENCES HOLDING. Daily Stock Analysis
Stock Information
Open
33.40
Close
33.27
High
33.42
Low
33.24
Previous Close
33.65
Daily Price Gain
-0.38
YTD High
37.26
YTD High Date
Jan 5, 2021
YTD Low
31.94
YTD Low Date
Mar 8, 2021
YTD Price Change
-3.83
YTD Gain
-10.32%
52 Week High
37.30
52 Week High Date
Nov 6, 2020
52 Week Low
31.94
52 Week Low Date
Mar 8, 2021
52 Week Price Change
-2.37
52 Week Gain
-6.65%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Dec 22. 2017
24.50
Jan 30. 2018
25.73
24 Trading Days
5.04%
Link
LONG
May 31. 2019
25.02
Jul 1. 2019
26.49
21 Trading Days
5.88%
Link
LONG
Jul 21. 2020
35.18
Aug 11. 2020
37.30
15 Trading Days
6.02%
Link
Company Information
Stock Symbol
IAU
Exchange
NasdaqGS
Company URL
http://www.integralife.com
Company Phone
6092750500
CEO
Peter J. Arduini
Headquarters
New Jersey
Business Address
311 ENTERPRISE DRIVE, PLAINSBORO, NJ 08536
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Instruments & Supplies
CIK
0000917520
About

Integra LifeSciences Holdings Corp. engages in the manufacture and sale of medical instruments, devices, and equipment. It operates through the Specialty Surgical Solutions, and Orthopedics and Tissue Technologies segments. The Specialty Surgical Solutions segment offers specialty surgical instrumentation for a broad range of specialties, such as products and solutions for dural repair, precision tools and instruments, tissue ablation, and neuro critical care. The Orthopedics and Tissue Technologies segment sells regenerative technology products that can be used to provide treatment for acute and chronic wounds, surgical tissue repair including hernia repair, peripheral nerve repair and protection, and tendon repair. It also sells hardware products, such as bone and joint fixation and joint replacement devices, implants and instruments, which provide for the orthopedic reconstruction of bone in the hand, wrist, elbow, and shoulder, the foot, ankle, and leg below the knee. The company was founded by Richard E. Caruso in 1989 and is headquartered in Plainsboro, NJ.

Description

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company operates through two segments, Specialty Surgical Solutions; and Orthopedics and Tissue Technologies. It offers neurosurgery and critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. The company also sells approximately 60,000 instrument patterns, and surgical and lighting products to hospitals, surgery centers, and dental, podiatry, and veterinary offices. In addition, it provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, the company sells hardware products, such as bone and joint fixation, and joint replacement devices; implants; and instruments, which provide for the orthopedic reconstruction of bone in the hand, wrist, elbow, and shoulder, as well as the foot, ankle, and leg below the knee in the extremity bone and joint reconstruction procedures. It offers its products directly through various sales forces and other distribution channels in the United States, Europe, and internationally. Integra LifeSciences Holdings Corporation was founded in 1989 and is headquartered in Plainsboro, New Jersey.